C4 Therapeutics, Inc.
Status: Publicly traded
Direct answer
C4 Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CCCC.
C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates. Its core strategy involves degrading proteins implicated in disease, addressing a range of conditions including cancer, neurodegenerative disorders, and other illnesses. The company's primary drug candidate, CFT7455, is an orally administered MonoDAC degrader of the IKZF1 and...
Can you invest in C4 Therapeutics, Inc.?
Yes. C4 Therapeutics, Inc. trades publicly on NASDAQ as CCCC.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for C4 Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.